Anaesthesia | 2021

Intravenous lidocaine: benefits require better evidence, and potential risks apply to all team members

 
 

Abstract


References 1. Pandit JJ, McGuire N. Unlicensed intravenous lidocaine for postoperative pain: always a safer ’licence to stop’ than to start. Anaesthesia 2021;76: 156–60. 2. Hollmann MW, Strumper D, Durieux ME. The poor man’s epidural: systemic local anesthetics for improving postoperative outcomes.Medical Hypotheses 2004;63: 386–9. 3. Vigneault L, Turgeon AF, Cote D, et al. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia 2011;58: 22–37. 4. Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database of Systematic Reviews 2015; 7: CD009642. 5. Grassi P, Bregant GM, Crisman M. Systemic intravenous lidocaine for perioperative pain management: a call for changing indications in the package sheet. Heart, Lung and Vessels 2014;6: 137–8.

Volume 76
Pages None
DOI 10.1111/anae.15439
Language English
Journal Anaesthesia

Full Text